Charles Dharmani

13PUBLICATIONS
48CO-AUTHORS
Health and ecological risk assessmentHaematological tumoursEpidemiological modellingDisease surveillanceNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 04, 2026
Assessing the effectiveness of the TURALIO (pexidartinib) risk evaluation and mitigation strategy program: patient knowledge, attitudes, and behavior survey (2020-2024).

|Aug 06, 2026
Adult T-cell Leukemia/Lymphoma in Japan: Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs.

|Jun 15, 2026
Peripheral T-cell Lymphoma in Japan: Real-World Patient Characteristics, Treatment Patterns, Healthcare Resource Utilization, and Costs.

|May 29, 2025
TURALIO® Risk Evaluation and Mitigation Strategy (tREMS) program: 5-year retrospective hepatic safety assessment.

Abdul Waheed Rajper, Charles Dharmani, Lalitha Chilakapati

|May 19, 2025
Identifying ventricular arrhythmia and sudden cardiac arrest in clinical notes of an electronic health record database.

Neil Dhopeshwarkar, Charles Dharmani, Oluwatosin Fofah

|Jul 18, 2024
TURALIO® Risk Evaluation and Mitigation Strategy Program (tREMS): 3-year retrospective hepatic safety assessment.

Charles Dharmani, Oluwatosin Fofah, Maura Fallon

Pageof 3

Frequent Collaborators

8 joint publications

Maribel Salas

8 joint publications

Oluwatosin Fofah

5 joint publications

Eric Wang

5 joint publications

Nora Tu